Strategic Partnering
Our Ambition
At BirchBioMed, we are committed to accelerating medical innovation and elevating patient care through the power of collaboration. Our strategic partnership opportunities are crafted to build alliances that capitalize on our cutting-edge research and development in targeted therapeutic areas. We are actively seeking to engage with industry leaders and forward-thinking innovators through two distinct partnership pathways:
Partnerships with Major OTC and Cosmetic Companies
We invite over-the-counter (OTC) and cosmetic companies to explore potential partnerships centered on our topical creams formulated with Kynurenic Acid (KynA). These products are expertly designed to target various skin-related conditions, offering effective and innovative solutions in the skincare market. We are open to discussions that would lead to exclusive partnership agreements for BirchBioMed’s topical product line. This is an excellent opportunity for companies looking to expand their product portfolios with scientifically backed advanced skincare treatments.
Partnerships with Big Pharma and Specialist Pharma Companies
BirchBioMed is poised to make significant strides in the pharmaceutical landscape with its novel, potentially groundbreaking approach to treating organ fibrosis and autoimmune disorders, initially focusing on:
Organ Fibrosis Treatments
Our portfolio includes treatments specifically designed for the systemic administration of Kynurenic Acid (KynA) to combat organ fibrosis, including challenging conditions like Idiopathic Pulmonary Fibrosis. We seek partners to further develop and commercialize these promising therapies.
Autoimmune Disorder Therapies
We are pioneering a therapeutic approach tailored for autoimmune disorders such as Type 1 Diabetes and Alopecia Areata. This strategy combines the systemic administration of KynA with a one-time delivery of APCs. We are interested in opening discussions with firms looking to expand into or enhance their portfolios in innovative autoimmune treatments.
We are committed to bringing these novel treatments to market, enhancing patient outcomes globally. Companies interested in exploring these opportunities are encouraged to contact us.
Therapeutic Market Sizes. GrandViewResearch, MarketResearchFuture, GlobeNewsWire, GlobalData.
Partner with us.
BirchBioMed is looking to engage with partners who have a strong interest in developing cutting-edge treatments and who are well-positioned to help bring these therapies to a global market. If this aligns with your company’s interests, BirchBioMed would welcome the opportunity to discuss potential collaboration.
Contact:
Hervé Girsault
herve.girsault@birchbiomed.com